Announcements Trials
Browse Landscape

Phase

Phase NA 60Phase 2 42Phase 1 31Phase 1/2 22Phase 3 16Phase 2/3 5Phase 4 3Phase EARLY_PHASE1 2

Status

Unknown 11Completed 9Recruiting 3Withdrawn 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 33Neoplasms 16Prostatic Neoplasms 15Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Liver Neoplasms 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Vomiting 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3

Interventions

remimazolam 1pembrolizumab 1enfortumab vedotin 1Specimen Handling 1Propofol 1Nephroureterectomy 1Metformin 1Magnetic Resonance Spectroscopy 1Hyperthermia, Induced 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Urinary Bladder Neoplasms × Clear all
NCT06764095 2026-02-12

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Mayo Clinic

Phase 4 Recruiting
75 enrolled
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Peking University First Hospital

Phase 4 Recruiting
1,128 enrolled
Genitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

NCT06215976 2024-08-20

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Cairo University

Phase 4 Recruiting
78 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡